Preparation and immunosuppressive activity of 32-(O)-acylated and 32- (O)-thioacylated analogues of ascomycin

Bioorganic and Medicinal Chemistry Letters

Volumn 9, Issue 2, 1999, Pages 227-232

  Hersperger, Rene ^a   Schuler, Walter ^a   Zenke, Gerhard ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ASCOMYCIN; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ACYLATION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CONFORMATIONAL TRANSITION; DRUG CONFORMATION; DRUG POTENCY; DRUG SYNTHESIS; IMMUNOREGULATION;

ACYLATION; ANTI-BACTERIAL AGENTS; ASTHMA; IMMUNOSUPPRESSIVE AGENTS; INHIBITORY CONCENTRATION 50; TACROLIMUS;

EID: 0033579950     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00702-1     Document Type: Article

References (25)

1. (a) Arai, T; Koyama, Y.; Suenaga, T.; Honda, H. J. Antibiot. 1962, Ser. A. 15, 231.
2. (b) Morisaki, M.; Arai, T. J. Antibiot. 1992, 45(1), 126.
3. Peters, D.H.; Fitton, A.; Plosker, G.L.; Faulds, D. Drugs 1993,46(4), 746.
4. Ho, S.; Clipstone, N.; Timmermann, L.; Northrop, J.; Graef, I.; Fiorentino, D.; Nourse, J.; Crabtree, G.R. Clin. Immunol. Immunopathol. 1996, 80(3), S40.
5. Keown, P.A. Drugs 1990, 40(3), 315.
6. Feutren, G. Transplant. Proceed. 1992, 24(4), 55.
7. Berth-Jones, J.; Henderson, C.A.; Munro, C.S.; Rogers, S.; Chalmers, R.J.; Boffa, M.J.; Norris, P.G.; Friedmann, P.S.; Graham-Brown, R.A.; Dowd, P.M.; Marks, R.; Sumner, M.J. Br. J. Dermatol. 1997, 136(4), 527.
8. (a) Ceyhan, B.B.; Sungur, M.; Celikel, C.A.; Celikel, T. Respiration 1998, 65(1), 71.
9. (b) Nagai, H.; Yamaguchi, S.; Tanaka, H., Inagaki, N. Int Arch Allergy Immunol 1995, 108(2), 189.
10. (a) Lock, S.H.; Kay, A.B.; Barnes, N.C. Am J Respir Crit Care Med 1996, 153, 509.
11. (b) Kay, A.B. Allergy Proc. 1994, 15(3), 147.
12. (a) Kay, A.B. In Ciba-found-symp. 1997, 206, 56-67; discussion 67-70, 106-10.
13. (b) Barnes, P.J. Br J Clin Pharmacol 1996, 42, 3.
14. (c) Corrigan, C.J.; Kay, A.B. Immunology Today 1992, 13(12), 501.
15. Mihatsch, M.J.; Kyo, M.; Morozumi, K.; Yamaguchi, Y.; Nickeleit, V.; Ryffel, B. Clinical Nephrology 1998, 49(6), 356.
16. (a) Waldrep, J.C.; Arppe, J.; Jansa, K.A.; Vidgren, M. Int. J. Pharm. 1998, 160(2), 239.
17. (b) Sihra, S.B.; Kon, O.M.; Durham, S.R.; Walker, S.; Barnes, N.C.; Kay, A.B. Thorax 1997, 52, 447.
18. Bou, V; Vilarrasa, J. Tetrahedron Lett. 1990, 31(4), 567.
19. Goerdeler, J.; Wieland, D. Chem. Ber. 1967, 100(1), 47.
20. 50 values for FK506 in the IL-2 RGA, the MLR and the MBA are 0.2nM, 0.3nM and 1.2nM, respectively.
21. 50 values for FK506 in the IL-2 RGA, the MLR and the MBA are 0.2nM, 0.3nM and 1.2nM, respectively.
22. Goulet, M.T.; Hodkey, D.W.; Staruch, M.J.; Dumont, F.J.; Lin, S.; Hung, S.H.Y.; Siekierka, J.J.; Wyvratt, M.J. Bioorg. Med. Chem. Lett. 1994, 4(7), 927.
23. (a) Kissinger, C.R.; Parge, H.E.; Knighton, D.R.; Lewis, C.T.; Pelletier, L.A.; Tempczyk, A.; Kalish, V.J.; Tucker, K.D.; Showalter, R.E.; Moomaw, E.W.; Gastinel, L.N.; Habuka, N.; Chen, X. Maldonado, F.; Barker, J.E., Bacquet, R.; Villafranca, J.E. Nature 1995, 378, 641.
24. (b) for the atomic structure of the FKBP12-FK506 binary complex, see: Van Duyne, G.D.; Standaert, R.F.; Karplus, P.A.; Schreiber, S.L.; Clardy, J. Science 1991, 252, 839.
25. Wagner, R.; Rhoades, T.A.; Or, Y.S.; Lane, B.C.; Hsieh, G.; Mollison, K.W.; Luly, J.R. J. Med. Chem. 1998, 41, 1764.